VENBIO PARTNERS
venBio invests in promising companies at various stages: from early to late stage, and from academic startups to spinouts. We tend to lead most of our investments, and we enjoy building syndicates and teams. We are mindful of potential acquisition partners from the outset, and we ensure that our companies are best positioned to meet their requirements. This includes IP, CMC, and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Our team’s expertise and involvement helps companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that we work with.
VENBIO PARTNERS
Social Links:
Industry:
Financial Services Life Science Venture Capital
Founded:
2009-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS GoDaddy DNS ASP.NET IIS IIS 10
Similar Organizations
JLS Fund
JLS Fund is a venture capital firm that invests in the psychedelics and technology intersection.
Shield Capital
Shield Capital is a venture capital firm that invests in founders building frontier technologies.
Tekton Ventures
Tekton Ventures is a seed-stage investment firm that partners with technology-focused entrepreneurs to build category defining companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-20 | ImmPACT Bio | venBio Partners investment in Series B - ImmPACT Bio | 111 M USD |
| 2022-01-19 | Ceptur Therapeutics | venBio Partners investment in Series A - Ceptur Therapeutics | 75 M USD |
| 2021-12-17 | NorthSea Therapeutics | venBio Partners investment in Series C - NorthSea Therapeutics | 80 M USD |
| 2021-11-29 | Ablaze Pharmaceuticals | venBio Partners investment in Series A - Ablaze Pharmaceuticals | 75 M USD |
| 2021-11-16 | ACELYRIN | venBio Partners investment in Series B - ACELYRIN | 250 M USD |
| 2021-10-19 | HistoWiz | venBio Partners investment in Series A - HistoWiz | 32.25 M USD |
| 2021-10-12 | CinCor Pharma | venBio Partners investment in Series B - CinCor Pharma | 143 M USD |
| 2021-09-20 | Ventyx Biosciences | venBio Partners investment in Series B - Ventyx Biosciences | 51 M USD |
| 2021-09-08 | Attralus | venBio Partners investment in Series B - Attralus | 116 M USD |
| 2021-09-08 | INBRACE | venBio Partners investment in Series D - INBRACE | 102 M USD |